Apollo Therapeutics
Focus: Apollo Therapeutics is a Cambridge-based Series B biotech focused on antibodies, fusion proteins, small molecules, and vaccines across infectious diseases and vaccines. The company operates at micro-scale (1-50 employees) with a diverse pipeline spanning oncology, dermatology, infectious disease, and medical devices.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Funding Stage
SERIES B
Employees
1-50
Total Funding
$260M
Open Jobs
0
About Apollo Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Apollo Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Apollo Wearable
Stress Disorders, Post-TraumaticClinical Trials (1)
NCT05274230Sustaining Remission From PTSD Using Tuned Vibroacoustic Stimulation (TVS) Following MDMA-Assisted Psychotherapy
N/AHelp build intelligence for Apollo Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.